Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

Researchers have developed new AI models that can vastly improve accuracy and discovery within protein science. The models ...

What to watch: AI and biotech are two of the biggest arenas for U.S.-China competition as the countries race to attract talent and potential partnerships — both with countries and companies.

Thank you for joining us on the “Enterprise AI hub.” In this episode, Jeff Kavanaugh, global head of the Infosys Knowledge ...

The convergence of artificial intelligence (AI) with biotechnology has contributed to the development of therapeutics and ...

Cambridge, MA – March 5, 2025 – Today, Insilico Medicine, a clinical-stage biotechnology company pioneering generative AI for drug discovery and development, announced the deployment of the ...

Cambridge, MA, Mar 3, 2025 --- Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia ...

Perhaps the most promising AI application is its potential to revolutionize medicine by accelerating the drug discovery process to deliver more effective therapies. Several biotechnology companies ...

and biotechnology through deep research and development in generative AI. In the FinTech and digital currency sectors, traditional operational models face numerous challenges, particularly in ...